Log in to search using one of your social media accounts:

 

Real 'Fault in Our Stars' couple: Katie Prager dies
Katie Prager, the wife in the real "Fault in Our Stars" couple, died Thursday after complications from cystic fibrosis and a lung transplant. She was 26 years old. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

'Fault in our Stars' wife dies 5 days after husband
Katie Prager died after complications from cystic fibrosis and a lung transplant. She was 26 years old. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

A real 'Fault in Our Stars' couple
Katie and Dalton Prager both had cystic fibrosis. Despite doctors' warnings, they married and became known as the real "Fault in Our Stars" couple. They passed away days apart from each other in September 2016. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

Dalton and Katie Prager: A love story
Katie and Dalton Prager both had cystic fibrosis. Despite doctors' warnings, they married and became known as the real "Fault in Our Stars" couple. They passed away days apart from each other in September 2016. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

A low-cost sensor for cystic fibrosis diagnosis
A new, inexpensive method for detecting salt concentrations in sweat or other bodily fluids has been developed by biomaterials scientists. The fluorescent sensor, derived from citric acid molecules, is highly sensitive and highly selective for chloride, the key diagnostic marker in cystic fibrosis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 20, 2016 Category: Science Source Type: news

Gene therapy for cystic fibrosis lung disease
Gene therapy may be a viable approach for treating or preventing lung disease caused by cystic fibrosis (CF), suggests new research. Working with CF pigs, the researchers have shown that two different virus-based vectors can restore a working version of the cystic fibrosis transmembrane conductance regulator (CFTR) protein that is faulty in CF to the pigs'airway cells. Moreover, this gene replacement normalized important aspects of the lung biology and improved the ability of airway secretions to kill bacteria. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 20, 2016 Category: Science Source Type: news

Husband in real-life "Fault in Our Stars" couple dies
25-year-old Dalton Prager died from cystic fibrosis, while his wife is in hospice care with the same disease (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 20, 2016 Category: Consumer Health News Source Type: news

New clues to cystic fibrosis'gender gap '
There is evidence that women with Cystic Fibrosis die on average two to three years earlier than do men with the devastating lung airway disease. A research team has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) " gender gap. " (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 19, 2016 Category: Science Source Type: news

[In Depth] Cystic fibrosis foundation opens drug discovery lab
The Cystic Fibrosis Foundation is once again breaking new ground. In 2000, with little beyond symptomatic relief available for the inherited, life-threatening condition, the Bethesda, Maryland–based foundation hired a biotech company to develop more effective treatments. The move, unprecedented for a disease advocacy organization, paid off in two new drugs, the first to target the molecular root of the disease. But there is still no cure, and cystic fibrosis patients continue to die—467 in the United States alone in 2014. So on 19 September, the foundation is setting another precedent by officially opening its ...
Source: ScienceNOW - September 15, 2016 Category: Science Authors: Bijal P. Trivedi Tags: Biomedicine Source Type: news

What Causes Hyperphosphatemia?
Discussion Constipation is a common problem in general pediatrics and its causes are numerous. It can cause acute and recurrent abdominal pain and is a cause of abdominal distention. Patients who are young, whose presentations are other than routine or who had complications should be invested for underlying causes of their constipation. This patient had undergone some evaluations in the past for constipation but because of the presentation of sepsis a more rigorous evaluation was undertaken. The differential diagnoses of the following can be found here: constipation, acute abdominal pain, recurrent abdominal pain, and abdo...
Source: PediatricEducation.org - September 12, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

New research sheds light'gender gap' in cystic fibrosis
Medical researchers have examined the underpinnings of cystic fibrosis, including its disproportionate effect on women -- due in part to the influence of estrogen on the flow of important chemical ions. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 10, 2016 Category: Science Source Type: news

New research sheds light 'gender gap' in cystic fibrosis
(Arizona State University) In new research appearing in the current issue of Science Advances, Wade Van Horn and colleagues from Vanderbilt and Northwestern Universities examine the underpinnings of cystic fibrosis, including its disproportionate effect on women -- due in part to the influence of estrogen on the flow of important chemical ions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 9, 2016 Category: Global & Universal Source Type: news

Sweat Chloride Test (Cystic Fibrosis)
Title: Sweat Chloride Test (Cystic Fibrosis)Category: Procedures and TestsCreated: 2/11/1999 12:00:00 AMLast Editorial Review: 9/7/2016 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 7, 2016 Category: Respiratory Medicine Source Type: news

Burkholderia cepacia: a Complex Problem for More than Cystic Fibrosis Patients
It is always surprising to find that an organism we know only from the clinical laboratory is a “player” in other venues. Therefore, it was with some fascination that we learned that Burkholderia cepacia, long known as a pathogen in cystic fibrosis patients, is also the number one organism isolated from product recalls. We recount the story of this amazing organism, which has a place in th e clinical, agricultural, and pharmaceutical sectors. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - September 3, 2016 Category: Microbiology Authors: Nehemiah J. Landes, Hannah N. Livesay, Fran Schaeffer, Pam Terry, Ernest Trevino, Alice Schauer Weissfeld Source Type: news

Genetic Factors Shed Light on Barrett's Esophagus, Adenocarcinoma Genetic Factors Shed Light on Barrett's Esophagus, Adenocarcinoma
Cystic fibrosis is among factors which may influence the complex relationship of genetics to Barrett's esophagus and adenocarcinoma, according to a large-scale meta-analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 2, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
Respiratory syncytial virus infection causes acute lung infection in infants and young children worldwide, resulting in considerable morbidity and mortality. Children with cystic fibrosis are prone to recurrent lung inflammation, bacterial colonisation and subsequent chronic airway disease, putting them at risk for severe respiratory syncytial virus infections requiring intensive care and respiratory support. No treatment currently exists, hence prevention is important. Palivizumab is effective in reducing respiratory syncytial virus hospitalisation rates and is recommended for prophylaxis in high-risk children with other ...
Source: Current Awareness Service for Health (CASH) - September 1, 2016 Category: Consumer Health News Source Type: news

Marijuana: Health effects of recreational and medical use
Marijuana is widely used, especially in adolescents and young adults. In the US, there are about 20 million users (about 7.5% of people aged 12 or older). Marijuana is a mind-altering (psychoactive) drug. Similar to hemp, it comes from the cannabis plant. The plant’s primary drug effects come from the chemical delta-9-tetrahydrocannabinol, or “THC.” Marijuana is smoked, “vaped” (inhaling the vapor), or ingested in foods or teas. Over the last few decades, the concentration of THC in the cannabis plant has been increasing. In addition, the plant extracts are more potent. Short-term effects of m...
Source: New Harvard Health Information - August 19, 2016 Category: Consumer Health News Authors: Wynne Armand, MD Tags: Behavioral Health Brain and cognitive health Drugs and Supplements Pain Management Source Type: news

Vertex Abandons Cystic Fibrosis Combo Trial
Boston-based biotech Vertex Pharmaceuticals will end a late-stage clinical study testing a two-drug combination therapy on cystic fibrosis patients after an independent board concluded the treatment wasn ’t showing meaningful benefit. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 17, 2016 Category: Pharmaceuticals Source Type: news

Sharing Mayo Clinic: Double Lung Transplant Recipient Beats Cystic Fibrosis
When Tammy Bolerjack was diagnosed with cystic fibrosis at age 18, she found herself frequently in and out of hospitals for treatments to help her breathe. Running 5K races and half-marathons certainly wasn ’t something she envisioned in her future. Little did she know then that eventually a double lung transplant at Mayo Clinic'sFlorida campus would not [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 13, 2016 Category: Databases & Libraries Source Type: news

Life And Love With A Chronic Illness
Time, it is a gift that is unassumingly stolen from us with every breath we take. It silently turns summer into fall, moments into memories, and days into decades. We wish it away while desperately clinging to it -- hoping to grip it tightly within the safety of our entangled fingers. But time is not ours to keep -- it's untamable and the very currency for which we trade to write the story of our unique and beautiful lives. Love And CF Eight years later I can still feel the words brushing against my lips as I said, "to have and to hold from this day forward." Forward. If only we truly understood what "forwa...
Source: Healthy Living - The Huffington Post - August 11, 2016 Category: Consumer Health News Source Type: news

Dr. George Scangos: Not just science for science ’s sake
America ’s biopharmaceutical researchers are working tirelessly to develop new and innovative medicines for patients. For those diseases that have no treatment options, the opportunity to improve patients’ lives provides daily inspiration to researchers.In anew video, George Scangos, Ph.D., chief executive officer at Biogen, says it was early in his career when he was researching treatments for children with cystic fibrosis that he fully understood the magnitude of his work. (Source: The Catalyst)
Source: The Catalyst - August 10, 2016 Category: Pharmaceuticals Tags: Alzheimer's Drug Development MS Source Type: news

PharmaTech LLC Issues Voluntary Nationwide Recall Due to Potential Risk of Product Contamination
PharmaTech, LLC of Davie, FL, is voluntarily recalling all liquid products from October 20, 2015 through July 15, 2016 as a precautionary measure due to a potential risk of product contamination with Burkholderia cepacia.If a product contains B. cepacia, its use could result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. Some of these infections may be serious or even life-threatening in the at risk patient population. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 9, 2016 Category: Food Science Source Type: news

NHS cut raft of new treatments after HIV drug High Court ruling
Toddlers with cystic fibrosis, children born deaf, adults who have lost their legs, and patients with cancer were among those who will no longer have access to planned new treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - August 4, 2016 Category: Consumer Health News Source Type: news

​Vertex plans to apply for approval of the drug that will replace Orkambi next year
Late Tuesday, Vertex Pharmaceuticals gave the latest sales figures for its newest drug to treat cystic fibrosis, called Orkambi, as well as a timeline for approval of the drug it hopes will replace it in a couple years. Shares of Boston-based Vertex (Nasdaq: VRTX) were trading about flat on Thursday morning after the company’s overall revenue and net income figures beat the bar set by analysts. Total revenue for the three months that ended in June was $432 million. That was made up mostly of sales… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 28, 2016 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news

Boy With Cystic Fibrosis Gets Wish To Be Garbage Man During 'Best Day Ever'
One sweet boy’s dream come true involved a lot of trash ― and that’s a good thing.  Ethan Dean, who has cystic fibrosis, has always been fascinated with waste management. So on Tuesday, the 6-year-old had the opportunity to live out his dreams of becoming a garbage man for a day and helped pick up trash around Sacramento, California, thanks to the Make-A-Wish foundation.  The experience, which was documented on social media with the hashtag #EthanCleansUp, was no disappointment as the boy told KCRA that he had the “best day ever!” The boy, who rode in the garbage truck with Waste Manage...
Source: Healthy Living - The Huffington Post - July 27, 2016 Category: Consumer Health News Source Type: news

Vertex Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
Vertex Pharmaceuticals Inc. said its second-quarter loss narrowed, as sales of its cystic fibrosis drugs continued to grow. (Source: WSJ.com: Health)
Source: WSJ.com: Health - July 27, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news

DNA sequencing uncovers latent risk for developing cystic fibrosis
All babies with a known mutation for cystic fibrosis (CF) and second mutation called the 5T allele should receive additional screening in order to better predict the risk of developing CF later in life, new research shows. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 25, 2016 Category: Science Source Type: news

DNA sequencing uncovers latent risk for developing cystic fibrosis
( Children's Hospital Los Angeles ) A study by researchers at Children's Hospital Los Angeles (CHLA), Brigham and Women's Hospital and the California Department of Public Health suggests that all babies with a known mutation for cystic fibrosis (CF) and second mutation called the 5T allele should receive additional screening in order to better predict the risk of developing CF later in life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 25, 2016 Category: Global & Universal Source Type: news

Children 'going blind and risk dying from cancer' as doctors overlook crucial NF1 signs
Despite being more common than cystic fibrosis and being linked to a number of serious complications, the incurable condition neurofibromatosis (NF1) is not checked for in infancy. (Source: the Mail online | Health)
Source: the Mail online | Health - July 24, 2016 Category: Consumer Health News Source Type: news

DNA-modulating drug attenuates lung inflammation in mice
( JCI Journals ) In this issue of JCI Insight, Jay Kolls and colleagues at the University of Pittsburgh demonstrate that bromodomain and extraterminal domain (BET) inhibitors, a class of drugs that alter DNA architecture and change gene expression, attenuate cystic fibrosis lung inflammation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 21, 2016 Category: Biology Source Type: news

7 Reasons Why Including Protein in Your Diet is a Must
When we think about protein, images of body builders and athletes come to mind. But protein has important health benefits for everyone, not just for sports enthusiasts eager to build muscle. To understand why this nutrient is so necessary in our diets, it's important to understand more about it. Think back to high school science class. Proteins are molecules that make sure that our bodies' organs and tissues function properly. They are also key components in our skin, eyes, hair, bones and nails. Proteins are made up of smaller molecules called amino acids. When we digest protein, the amino acids are what's left. These un...
Source: Healthy Living - The Huffington Post - July 19, 2016 Category: Consumer Health News Source Type: news

PharmaTech LLC Issues Voluntary Nationwide Recall of Diocto Liquid Distributed by Rugby Laboratories Due to Product Contamination
PharmaTech LLC of Davie, FL, the manufacturer of the Rugby®- branded product, is voluntarily recalling all lots within the expiry of Diocto Liquid, a docusate sodium solution due to a risk of product contamination with Burkholderia cepacia. Use of docusate sodium liquid contaminated with B. cepacia may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 16, 2016 Category: Food Science Source Type: news

The adorable moment girl claps after giving HERSELF her cystic fibrosis medicine
Talia Coombs, from Warrington, pushes four plastic syringes filled with medication into her mouth without complaint - before clapping and asking for more. The clip has been seen by 100,000 people. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2016 Category: Consumer Health News Source Type: news

Personalized Medicine: The Way Forward?
This article will look at some of the strategies already available to help healthcare professionals meet individual patient needs, in the multifaceted field of personalized medicine. Personalizing drug therapy for depression Research suggests that around 50 percent of patients with depression do not respond to first-line antidepressants. What can explain this, and how can it be solved? Current treatment is often a case of trial and error. A patient may take one medication after another, often for 12 weeks or more each time, while symptoms remain the same, or worsen. A team from King's College London in the United Kingd...
Source: Healthy Living - The Huffington Post - July 6, 2016 Category: Consumer Health News Source Type: news

Cystic fibrosis sufferer claims POLE VAULTING saved his life 
When Jerry Cahill was diagnosed in New York in 1974, cystic fibrosis sufferers were not expected to live past 16. Even now, the average life expectancy of a CF sufferer is 36. Jerry is 60. (Source: the Mail online | Health)
Source: the Mail online | Health - July 4, 2016 Category: Consumer Health News Source Type: news

Breathing in a Cure: Inhalable Ibuprofen on the Horizon
Ibuprofen: You can buy it at any drug store, and it will help with that stabbing headache or sprained ankle. One of the ways it does so is by reducing inflammation, and it is this property that may also help patients with cystic fibrosis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 2, 2016 Category: Science Source Type: news

Burden on patients: Insurance benefit design’s impact on patient access to medicines
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents data on access to medications for chronic conditions in exchange plans. (Source: The Catalyst)
Source: The Catalyst - June 30, 2016 Category: Pharmaceuticals Tags: Access diabetes health insurance Burden on Patients Asthma Rheumatoid Arthritis exchanges Access Better Coverage ABCs of Coverage high cholesterol Policy Solutions Empower Consumers Source Type: news

Burden on patients: Insurance benefit design ’s impact on patient access to medicines
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS , oncology , cystic fibrosis , mental health and multiple sclerosis . The analysis by Avalere Health presents data on access to medications for chronic conditions in exchange plans. (Source: The Catalyst)
Source: The Catalyst - June 30, 2016 Category: Pharmaceuticals Tags: Access diabetes health insurance Burden on Patients Asthma Rheumatoid Arthritis exchanges Access Better Coverage ABCs of Coverage high cholesterol Policy Solutions Empower Consumers Source Type: news

‘What a difference a year makes’: Catching up with liver brothers Brent and Malambo
Brent and Malambo We are honored U.S. News & World Report has named Boston Children’s Hospital the #1 pediatric hospital in the U.S. As we celebrate this honor, we’re reflecting on some of the greatest children’s stories ever told — stories of the patients and families whose lives touch ours and inspire us. Two of those patients are “liver brothers” Malambo Mazoka-Tyler and Brent Groder. Malambo and Brent are, by all standards, oceans apart. Zambian-born Malambo is nearly two. His world, one year after a life-saving, split-liver transplant, is all about walking and talking,...
Source: Thrive, Children's Hospital Boston - June 29, 2016 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories biliary atresia cystic fibrosis liver failure Liver transplant Liver Transplant Program Pediatric Transplant Center (PTC) split-liver transplant Source Type: news

Pole Vaulter With Cystic Fibrosis Clears Odds For Survival
BOSTON (CBS) — Clearing the bar and the challenges of life and living with cystic fibrosis far longer than anyone thought he would, Jerry Cahill says exercise has made all the difference.  He is in Boston for the premiere of a documentary about his extraordinary life.  This pole vaulter from New York not only has beaten the odds, he’s crushed them. “I’m 60 years old today, yes,” says Cahill smiling. And that’s a remarkable feat.  Jerry was diagnosed with cystic fibrosis when he was a kid. “You build up a bacteria, the mucus gets really thick, and it st...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 27, 2016 Category: Consumer Health News Authors: larasalahi Tags: Health Local News Syndicated Local CBS Boston Dr. Mallika Marshall WBZ Source Type: news

[This Week in Science] Mini-guts for testing drug therapy
Author: Orla M. Smith (Source: ScienceNOW)
Source: ScienceNOW - June 23, 2016 Category: Science Authors: Orla M. Smith Tags: Cystic Fibrosis Source Type: news

Burden on patients: Access to medicines in health insurance exchange plans
Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still struggle to get the medicines they need due to high out-of-pocket costs and other plan restrictions. We looked at the burden on patients with health insurance exchange coverage in 2014 and 2015. Now, we’re taking a look at 2016 coverage. (Source: The Catalyst)
Source: The Catalyst - June 23, 2016 Category: Pharmaceuticals Tags: Access Cystic Fibrosis health insurance HIV/AIDS Burden on Patients Multiple Sclerosis exchanges Mental Health Oncology Access Better Coverage ABCs of Coverage Policy Solutions Empower Consumers Source Type: news

Stem cells from human INTESTINES could help treat rare life-threatening cystic fibrosis
SCIENTISTS from the Netherlands have revealed that stem cells from intestines of cystic fibrosis patients can predict if a specific medicine will be effective for sufferers of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - June 23, 2016 Category: Consumer Health News Source Type: news

NICE issues Final Appraisal Determination for Vertex’s Orkambi to treat cystic fibrosis
The National Institute for Health and Care Excellence (NICE) in the UK has issued a Final Appraisal Determination (FAD) for Massachusetts-based pharmaceutical company Vertex’s Orkambi (lumacaftor / ivacaftor), as a new therapy for treating cystic fib… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 19, 2016 Category: Pharmaceuticals Source Type: news

THOUSANDS with life-threatening cystic fibrosis will miss out on ‘breakthrough’ treatment
ALMOST 3,000 people with cystic fibrosis will miss out on a ‘breakthrough’ treatment after the health watchdog turned it down for use on the NHS. (Source: Daily Express - Health)
Source: Daily Express - Health - June 17, 2016 Category: Consumer Health News Source Type: news

Cystic fibrosis drug Orkambi 'too pricey for the NHS'
The National Institute for Health and Care Excellence rejected the drug, which has been shown in clinical trials to improve lung function and respiratory symptoms in people with cystic fibrosis. (Source: the Mail online | Health)
Source: the Mail online | Health - June 17, 2016 Category: Consumer Health News Source Type: news

Cystic fibrosis sufferer Jessica Bean credits sugar-free lifestyle with saving her life
A sugar free diet has been credited with everything from extreme weight loss to healing acne. Now cystic fibrosis sufferer, Jessica Bean, 28, from Queensland claims cutting out sugar saved her life. (Source: the Mail online | Health)
Source: the Mail online | Health - June 17, 2016 Category: Consumer Health News Source Type: news

BREXIT: Is the Pharmaceutical Industry at Risk?
In general, the pharmaceutical industry has benefited from the UK being within the European Union; from centralized European drug approvals that simplify the regulatory process to research funding grants that support universities and innovation. The full impact of a potential Brexit on market access, patient access and innovation is still unknown. What impact would Brexit have on pricing? The majority of European countries use an International Reference Pricing (IRP) mechanism to establish the price of a new pharmaceutical product. While most of these countries would not be impacted directly by Brexit, countries that refer...
Source: EyeForPharma - June 17, 2016 Category: Pharmaceuticals Authors: Preeti Patel Source Type: news

Raptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR(TM) at the 39th European Cystic Fibrosis Conference
NOVATO, Calif., June 10, 2016 -- (Healthcare Sales & Marketing Network) -- Raptor Pharmaceutical Corp. (RPTP), a biopharmaceutical company developing and commercializing transformative treatments for rare diseases, today announced new data analyses of its ... BiopharmaceuticalsRaptor Pharmaceutical, QUINSAIR, Cystic Fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2016 Category: Pharmaceuticals Source Type: news

The future of gene research - podcast
How does our genetic makeup help or hinder our chances in life? And as our ability to unravel DNA becomes more powerful, what are the implications?Scientists are finding ways to alter the genetic makeup of children with harmful mutations such as cystic fibrosis and muscular dystrophy. Will we soon see more complex disorders such as cancers and heart disease being tackled in this way, by altering or replacing entire groups of genes? To tackle these questions and more, Ian Sample is joined in the studio by Siddharta Mukherjee, whose new book spans the history of genetics, from Gregor Mendl’s 19th century experiments to...
Source: Guardian Unlimited Science - June 10, 2016 Category: Science Authors: Ian Sample, Siddhartha Muherjee (contributor) and Iain Chambers Tags: Science Genetics Biology Health & wellbeing Source Type: news